GleamWall
中文EN

BDSX BIODESIX INC

Services-Medical Laboratories · Nasdaq · SEC CIK 1439725 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY31.2%
TTM net income YoY31.5%
TTM EPS YoY49.0%
Revenue 3-yr CAGR33.7%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-18.7%
Net margin-25.7%
FCF margin-18.1%
EBITDA margin-13.4%

Returns

ROE-778.9%
ROA-29.6%
ROIC (approx.)-50.2%
Asset turnover1.15x

Leverage & solvency

Liabilities / assets90.8%
Debt / equity5.76x
Current ratio2.96x
Interest coverage-2.45x

Cash quality & payout

Operating cash flow / net income0.67x
Accruals ratio-9.8%
Payout ratio—
Capex / revenue0.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$88.50M$71.32M
R&D expense$12.00M$9.56M
SG&A expense$87.55M$80.45M
Operating income-$27.87M-$34.50M
Interest expense$7.72M$8.26M
Income tax$0$0
Net income-$35.27M-$42.93M
EBITDA-$22.20M-$28.73M
EPS (basic)-4.67-6.64
EPS (diluted)-4.67-6.64
Weighted avg. shares (diluted)7.55M6.47M
Banking
Provision for credit losses$180,000$887,000
Balance sheet
Cash & equivalents$18.99M$26.33M
Receivables$9.04M$8.60M
Current assets$32.52M$39.48M
PP&E, net$24.82M$27.83M
Goodwill$15.03M$15.03M
Intangibles$3.88M$5.87M
Total assets$87.48M$97.24M
Current liabilities$17.44M$14.32M
Long-term debt$50.01M$40.03M
Total debt$50.01M$40.03M
Total liabilities$89.94M$76.37M
Shareholders' equity-$2.46M$20.88M
Net debt$31.02M$13.69M
Shares outstanding8.25M7.27M
Cash flow statement
Operating cash flow-$23.27M-$48.65M
Capital expenditure$259,000$3.23M
Free cash flow-$23.53M-$51.88M
Investing cash flow-$403,000-$3.44M
Financing cash flow$16.42M$52.05M
Depreciation & amortization$5.67M$5.77M
Stock-based compensation$4.14M$6.64M

Free plan shows the latest 2 periods; Pro shows all 7 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.